博士課程の2年度の薬局在留プログラムディレクター間の移行をナビゲートするための実践的なヒント
Kari Taggart1, Kyle Dvoracek2, Shanna K O'Connor3
1Avera McKennan Hospital and University Health Center, Sioux Falls, SD, USA.
まとめ
薬局レジデンスプログラムディレクター (RPD) のための構造化されたリーダーシップ移行計画は,プログラムの品質を維持しました. 成功の鍵となる要因は,手渡しプロセス中にRPDの専門知識と適応力を活用することでした.
科学分野:
- 薬局 教育 教育 薬局教育
- リーダーシップ開発 リーダーシップ開発
- ヘルスケア・マネジメント・ヘルスケア・マネジメント
背景:
- 薬局レジデンスプログラムにおけるリーダーシップの移行は,プログラムの継続性と品質に影響を及ぼします.
- レジデンスプログラムディレクター (RPD) の役割の移転について,確立されたベストプラクティスの欠如があります.
研究 の 目的:
- ASHP認定プログラムにおけるRPDの役割への移行のための縦断的なプロセスを記述し,評価する.
- RPDのリーダーシップの継承のためのベストプラクティスを確立する.
主な方法:
- 12ヶ月のRPD移行からの文書と資料の体系的なレビュー.
- 研究チームによるコンセンサスに基づく移行要素の分類.
- プログラムメトリックの評価 (応募者数,評価のタイミング) 移行前,移行中,移行後の評価.
主要な成果:
- 詳細な移行タイムラインとタスクリストが作成されました.
- プログラムの品質指標は安定したままでいたか,改善した.
- 応募者数は維持され,タイムリーな評価は増加したが,初期開発計画はわずかに減少した.
結論:
- 構造化されたRPD移行計画は,プログラム品質の維持とスムーズな継承を促進します.
- RPDに特有のスキルを活用し,適応への開放性を育成することは,成功する移行に不可欠です.
関連する概念動画
Drug Dosing: Geriatric Patients
281
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
281
IV Infusion to Oral Dosing: Conversion Methods
13
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
13
Discharge Summary Forms
1.3K
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.3K
Drug Administration and Therapy Phases: Overview
1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K
Dosage Regimens: Designs and Approaches
347
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
347
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
268
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
268


